Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Chan, P. K.
Right arrow Articles by Aderinto, J.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The outcome of total hip arthroplasty in diabetes mellitus

Peter Kh Chan

7 Alton Avenue, Nottingham, NG11 7DR, UK, drpete18{at}doctors.org.uk

Ivan J Brenkel

Department of Orthopaedics, Queen Margaret Hospital, Whitefield Road, Dunfermline, Fife, KY12 0SU, UK

Joseph Aderinto

Department of Orthopaedics, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SA, UK

n analysis on prospective data on our hip database was carried out on all patients undergoing primary cemented unilateral total hip arthroplasty. There were 1,220 non-diabetic and 77 diabetic patients identified with at least three years follow-up. We found no significant difference with respect to age, sex and diagnosis between the two groups. Diabetic patients did have a significantly higher body mass index (BMI) and higher incidence of coronary artery disease. We found no increase in the rate of deep periprosthetic infection, superficial wound complications, dislocation, blood loss and deep vein thrombosis (DVT) between patients with and without diabetes even after adjusting for potential confounders. Diabetic patients had a longer length of stay (10.73 versus 9.56 days, p<0.05). Further analysis of the diabetic group showed no difference, with the same outcomes in patients between insulin-dependent and non-insulin dependent diabetic subsets. From this study we conclude that at the time of taking informed consent from patients undergoing total hip arthroplasty the only potential difference between those with and without diabetes is that the length of stay may be longer for patients with diabetes. Br J Diabetes Vasc Dis 2005;5:146—9

Key Words: hip arthroplasty • diabetes • infection • outcome.

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 3, 146-149 (2005)
DOI: 10.1177/14746514050050030601
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?